In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Alignment Healthcare Inc (NASDAQ: ALHC) closed at $11.16 down -2.79% from its previous closing price of $11.48. In other words, the price has decreased by -$2.79 from its previous closing price. On the day, 3.29 million shares were traded. ALHC stock price reached its highest trading level at $11.655 during the session, while it also had its lowest trading level at $10.95.
Ratios:
For a deeper understanding of Alignment Healthcare Inc’s stock, let’s take a closer look at its various ratios. In the meantime, Its Debt-to-Equity ratio is 1.92 whereas as Long-Term Debt/Eq ratio is at 1.91.
On May 30, 2024, BofA Securities Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $7.75 to $11.
On May 30, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $10.Robert W. Baird initiated its Outperform rating on May 30, 2024, with a $10 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 15 ’24 when Maroney Dawn Christine sold 30,000 shares for $11.35 per share. The transaction valued at 340,560 led to the insider holds 1,696,097 shares of the business.
KONOWIECKI JOSEPH S sold 6,920 shares of ALHC for $95,012 on Nov 11 ’24. The Director now owns 1,134,888 shares after completing the transaction at $13.73 per share. On Nov 11 ’24, another insider, Freeman Robert Thomas, who serves as the Chief Financial Officer of the company, sold 30,500 shares for $13.42 each. As a result, the insider received 409,356 and left with 92,929 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALHC now has a Market Capitalization of 2140285824 and an Enterprise Value of 1980577920. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.78 while its Price-to-Book (P/B) ratio in mrq is 18.67. Its current Enterprise Value per Revenue stands at 0.803 whereas that against EBITDA is -21.142.
Stock Price History:
Over the past 52 weeks, ALHC has reached a high of $14.25, while it has fallen to a 52-week low of $4.46. The 50-Day Moving Average of the stock is -3.95%, while the 200-Day Moving Average is calculated to be 35.66%.
Shares Statistics:
For the past three months, ALHC has traded an average of 1.53M shares per day and 2738270 over the past ten days. A total of 188.95M shares are outstanding, with a floating share count of 91.87M. Insiders hold about 52.08% of the company’s shares, while institutions hold 42.61% stake in the company. Shares short for ALHC as of 1730332800 were 4508811 with a Short Ratio of 2.94, compared to 1727654400 on 3911333. Therefore, it implies a Short% of Shares Outstanding of 4508811 and a Short% of Float of 3.6700000000000004.
